Study aims to identify Parkinson's biomarkers

07/28/2013 | American City Business Journals

Researchers at the Emory University School of Medicine are planning a study to analyze the possibility of diagnosing asymptomatic Parkinson's disease. The study will examine biomarkers indicative of disease progression, with researchers performing SPECT imaging, MRI and other tests to trace the progression to symptomatic disease. The research is part of the Parkinson's Progression Markers Initiative, created by The Michael J. Fox Foundation for Parkinson's Research.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX